What is the ticker symbol for Minerva Neurosciences?

Minerva Neurosciences trades under the ticker NERV on NASDAQ.

What sector does Minerva Neurosciences operate in?

Minerva Neurosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NERV in a portfolio?

PortView shows NERV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Minerva Neurosciences (NERV) Stock Analysis

NASDAQHealthcareBiotechnology

$4.53+1.12%

1-year price historyRange $2.03 – $8.07

52-week range$4.53

$1.93$12.46

What Minerva Neurosciences does

Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system. Its portfolio of experimental treatments notably features roluperidone, an investigational drug aimed at managing schizophrenia, alongside MIN-301, a soluble recombinant variant of the neuregulin-1b1 protein, which is being explored for its potential in treating Parkinson's disease and various other neurodegenerative conditions. The company has a contractual licensing agreement with Mitsubishi Tanabe Pharma Corporation, authorizing the worldwide development, distribution, and import of roluperidone, with the explicit exclusion of the Asian continent. Established in 2007, this organization initially operated as Cyrenaic Pharmaceuticals, Inc. before undergoing a name change to Minerva Neurosciences, Inc. in 2013. Its corporate headquarters are located in Waltham, Massachusetts.

Key metrics

Market cap

$211.05M

P/E (TTM)

-1.06

EPS (TTM)

$-4.29

Beta

-0.11

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$4.51

200-day avg

$5.07

52-week high

$12.46

52-week low

$1.93

CEO

Remy Luthringer

ETFs linked to NERV

Broad-market and Healthcare sector ETFs an investor holding Minerva Neurosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NERV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NERV in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Minerva Neurosciences?: Minerva Neurosciences trades under the ticker NERV on NASDAQ.
Which exchange is NERV listed on?: NERV is listed on NASDAQ.
What sector does Minerva Neurosciences operate in?: Minerva Neurosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NERV in a portfolio?: PortView shows NERV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.